Search

Your search keyword '"Ben Yaghlene, L."' showing total 4 results
Start Over Author "Ben Yaghlene, L."
4 results on '"Ben Yaghlene, L."'

1. Oral communication and poster abstracts of the 22nd National Congress of Gastroenterology joint to the 4th Maghrebian Congress of Gastroenterology. December 2018

Author

Bellabah, A., Benkirane, A., Ibrahimi, A., Nakhli, A., Sair, A., Essaid, A., Blel, A., Lahchaichi, A., Ben Slama, A., Ouni, A., Amouri, A., Jemaa, A., Cherif, A., Khsiba, A., Hssine, A., Djobbi, A., Guedich, A., Laabidi, A., Mensi, A., Ouakaa, A., Sriha, A., Choukri, A., Green, A., Belkhamsa, A., Hammami, A., Bourigua, A., Filali, A., Belabeh, A., Sentissi, A., Ait Errami, A., Nadi, A., Filankembo, A., Lamine, A., Badre, W., Ben Kaab, B., Ben Slimane, B., S, B., Hasnaoui, B., Bouchabou, B., Bouguerra, C., Baccouche, C., Ayadi, C., Bennasrallah, C., Benajah, D., Gargouri, D., Zehi, D., Issaoui, D., Cherif, D., Ben Ghachem, D., Trad, D., Bouaiti, E., Boutouria, E., Bel Hadj Mabrouk, E., Chalbi, E., Aait, E., Bouhamou, F., Haddad, F., Lairani, F., Saffar, F., Torjmen, F., Haj Kacem, F., Hamdane, F., Chabib, F. Z., Elrhaoussi, F. Z., Moumayez, F. Z., Loukil, F., Ahmed Djouldé Diallo, F., Aissaoui, F., Ajana, F., Chabib, F., Hamdoun, F., Moumayez, F., Bennani Kella, G., Bennani, G., Abid, H., Cheikhani, H., Ouazzani, H., Romdhane, H., Hassan SEDDIK, Sghir, H., Debbabi, H., Ben Jeddi, H., Garraoui, H., Letaief, H., Kchir, H., Elloumi, H., Hammami, H., Jaziri, H., Ben Abdallah, H., Chaabouni, H., Ben Romdhane, H., Yacoub, H., Gdoura, H., Sahli, H., Loghmari, H., Bouguerra, H., Maghrebi, H., Ben Nejma, H., Jlassi, H., Fourati, H., Alaoui, H., Ismail, H., Benelbarhdadi, I., Cohen, I., Errabih, I., Koti, I., Doghri, I., Elhidaoui, I., Haraki, I., Cheikh, I., Abdelaali, I., Jemni, I., Bouennene, I., Akoch, I., H, I., Boubaker, J., Krati, K., Eljery, K., Temani, K., Bellil, K., Chabbouh, K., Boughoula, K., Ouazzani, L., Ben Yaghlene, L., Kallel, L., A, L., Hamzaoui, L., Chtourou, L., Ben Farhat, L., Bouabid, L., Mnif, L., Mouelhi, L., Safer, L., Zouiten Mekki, L., Bourehma, M., El Akbari, M., El Khayari, M., Elyousfi, M., Firwana, M., Lahlali, M., Tahiri, M., Mestouri, M., Abdelwahed, M., Ben Hamida, M., Ben Chaabane, M., Moalla, M., Yakoubi, M., Sabbah, M., Serghini, M., Amri, M., Ben Abbes, M., Ben Cheikh, M., Ghribi, M., Hafi, M., Ben Abdelwahed, M., Ksiaa, M., Essid, M., Zakhama, M., Yousfi, M., Ayari, M., Belhadj, M., Cheickh, M., Kacem, M., Horma Alaoui, M., Abid, M., Bennour, M. A., Ghanem, M., Loghmari, M. H., Douggui, M. H., Azouz, M. M., Abdelli, M. N., Boudabous, M., Feki, M., Fekih, M., Mahmoudi, M., Boudabbous, M., Figuigui, M., Medhioub, M., Safer, M., Azzouz, M., Abbes, M., El Abkari, M., Aqodad, N., Azib, N., Bellil, N., Benhoumane, N., Benzoubbeir, N., Elkhabiz, N., Hemdani, N., Lahmidani, N., Abdelli, N., Ben Chaabane, N., Tahri, N., Benhoummane, N., Ben Jaafar, N., Ben Mustapha, N., Maamouri, N., Hannachi, N., Ben Alaya, N., Bibani, N., Trad, N., Elleuch, N., Kharmach, O., Bahri, O., Bousnina, O., Gharbi, O., Benjira, R., Ennaifer, R., Dabbèche, R., Jouini, R., Zgolli, R., Baklouti, R., Bouali Mohamed, R., Marouani, R., Kallel, R., Berrag, S., El Yazal, S., Jiddi, S., Mechhour, S., Morabit, S., Oubaha, S., Sentissi, S., Bouaziz, S., Soua, S., Hachicha, S., Elaboudi, S., Ajmi, S., Mallat, S., Bouchoucha, S., Mrabti, S., Ben Slama, S., Hamdi, S., Laabidi, S., Ayadi, S., Hidri, S., Bizid, S., Ben Hamida, S., Zertiti, S., Ben Amor, S., Nsibi, S., Bellakhal, S., Bahja, S., Jomni, T., Hliwa, W., Rebai, W., Ben Mansour, W., Ben Othmen, W., Dhouib, W., Hammoumi, W., Zaatour, W., Bouhlel, W., Feki, W., Triki, W., Said, Y., Zaimi, Y., Gorgi, Y., Bouhnoun, Z., Samlani, Z., Hamidi, Z., Mnif, Z., and Ben Safta, Z.

2. Macrocystic pancreatic cystadenoma: The role of EUS and cyst fluid analysis in distinguishing mucinous and serous lesions.

Author

O'Toole D, Palazzo L, Hammel P, Ben Yaghlene L, Couvelard A, Felce-Dachez M, Fabre M, Dancour A, Aubert A, Sauvanet A, Maire F, Lévy P, and Ruszniewski P

Subjects
Adolescent, Adult, Aged, Antigens, Tumor-Associated, Carbohydrate analysis, Biomarkers, Tumor analysis, Biopsy, Fine-Needle, CA-19-9 Antigen analysis, Carcinoembryonic Antigen analysis, Cystadenoma, Mucinous diagnostic imaging, Cystadenoma, Mucinous pathology, Cystadenoma, Serous diagnostic imaging, Cystadenoma, Serous pathology, Diagnosis, Differential, Female, Humans, Male, Middle Aged, Mucin-1 analysis, Pancreatic Neoplasms diagnostic imaging, Pancreatic Neoplasms pathology, Predictive Value of Tests, Sensitivity and Specificity, Cyst Fluid chemistry, Cystadenoma, Mucinous diagnosis, Cystadenoma, Serous diagnosis, Endosonography, Pancreatic Neoplasms diagnosis
Abstract

Background: Benign pancreatic serous cystadenoma usually is morphologically distinguishable from mucinous cystadenomas, which require resection because of their malignant potential. A macrocystic variant of serous cystadenoma recently has been described, rendering this important distinction more difficult. The aim of this study was to determine the EUS and tumor marker characteristics of mucinous cystadenoma compared with macrocystic serous cystadenomas., Methods: Medical records for consecutive patients seen between 1995 and 2002, with a histopathologic diagnosis of mucinous cystadenoma or macrocystic serous cystadenoma after surgery, who had undergone a detailed EUS examination, including EUS-guided FNA, were retrospectively reviewed., Results: A resection specimen was available for 32 mucinous cystadenomas and 9 macrocystic serous cystadenomas. No significant differences were observed with regard to clinical data (age, gender, presence of symptoms), lesion size, and location within the pancreas. All mucinous cystadenomas had a discernible cyst wall (thickened, 66%; focal parietal nodules, 25%) compared with 56% of macrocystic serous cystadenomas (p<0.0001). A thick echo content also was more frequent in mucinous cystadenoma (56% vs. 11%; p=0.04; statistical significance removed by the Bonferroni correction). Microcysts were only observed in macrocystic serous cystadenomas (44%; p=0.0008). The combination of a cyst wall that is thickened and the absence of microcysts had a sensitivity of 100% and specificity of 78% for the diagnosis of mucinous cystadenoma compared with macrocystic serous cystadenoma. Although intracystic carbohydrate-associated antigen 72-4 and mucins M1 were non-discriminatory, low carcinoembryonic antigen (<5 ng/mL) and carbohydrate-associated antigen 19-9 (<50,000 U/mL) values were found in macrocystic serous lesions (respectively, 100% and 100%; p=0.0002 and p=0.0002)., Conclusions: Although there is considerable overlap, helpful EUS characteristics that differentiate mucinous cystadenoma from macrocystic serous cystadenoma include a thick cyst wall and microcysts. These features, coupled with analysis of aspirated fluid for tumor markers (especially carcinoembryonic antigen), should help to confirm the diagnosis.

Published
2004
Full Text
View/download PDF

3. [Corticosteroid dependence and resistance in Crohn's disease: prevalence and predictive factors].

Author

Karoui S, Ben Yaghlene L, Fekih M, Boubaker J, and Filali A

Subjects
Adrenal Cortex Hormones adverse effects, Adult, Crohn Disease epidemiology, Crohn Disease pathology, Drug Resistance, Female, Humans, Male, Prevalence, Retrospective Studies, Risk Factors, Adrenal Cortex Hormones pharmacology, Crohn Disease drug therapy
Abstract

The aim of our study was to determine the prevalence of corticosensibility, corticodependency, and corticoresistance in patients with Crohn's disease. Ninety four treatments with corticoids were prescribed to the patients during the follow-up. The rates of corticosensibility, corticodependency, and corticoresistance were 66%, 16%, 18%. Corticodependency and corticoresistance are frequent in Crohn's disease. Corticodependency is more frequent in young patients and when corticoids were previously taken. A high CDAI was the only factor associated with a higher risk of corticoresistance.

Published
2003

4. [Association of asymptomatic celiac disease and Crohn's disease].

Author

Karoui S, Boubaker J, Hamzaoui S, Ben Yaghlene L, and Filali A

Subjects
Adult, Antibodies blood, Biopsy, Celiac Disease diagnosis, Celiac Disease diet therapy, Celiac Disease immunology, Crohn Disease diagnosis, Crohn Disease drug therapy, Female, Gastrointestinal Agents therapeutic use, Gliadin immunology, Humans, Sulfasalazine therapeutic use, Celiac Disease complications, Crohn Disease complications
Abstract

A 24-year-old woman had Crohn's colitis which had been diagnosed in 1997. The patient was given sulfazalazine and responded well. Antiendomysial and antigliadin antibodies were positive. Diagnosis of celiac disease was confirmed by duodenal biopsy showing villous atrophy and an increased number of lymphocytes infiltrating the epithelium. Few cases associating Crohn's disease and celiac disease have been reported. This case illustrates the complexity of the pathogenic mechanisms in these two disease. Our patient required a gluten-free diet although the celiac disease was asymptomatic, basically to avoid the risk of malignancy associated with celiac disease.

Published
2000

Catalog

Books, media, physical & digital resources
See catalog results